Muscle loss linked to immunotherapy response in lung cancer
NCT ID NCT07192926
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This study looked at 115 people with advanced lung cancer to see if muscle loss (sarcopenia) and a blood-based score called CTI could predict how well immunotherapy works. Researchers reviewed medical records and CT scans from patients treated at a single hospital. The goal is to find simple markers that help doctors choose the best treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Etlik City Hospital Medical Oncology Department
Ankara, Yenimahalle, 06270, Turkey (Türkiye)
-
Etlik City Hospital Radiology Department
Ankara, Yenimahalle, 06270, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.